Introduction to Synuclein Biomarkers: How Researchers are “Seeing” Lewy Bodies in the Living Brain

The Lewy Body Dementia Association (LBDA) is proud to present the third webinar of 2024 'Introduction to Synuclein Biomarkers: How Researchers are “Seeing” Lewy Bodies in the Living Brain.’
Hosted by Dr. Kathleen Poston, a leading figure in Lewy body dementia (LBD) research and care and co-lead of the LBDA Research Center of Excellence at Stanford University, this webinar discussed the currently available synuclein biomarkers.
During the session, Dr. Poston also explored the recent advances in the development of biomarkers for alpha-synuclein, how they are changing research in LBD, and how they may change clinical practice in the future.
Chapters:
0:00 - Relevant resources & information
8:16 - Webinar introduction with Keith N. Fargo, PhD
13:24 - Intro to Lewy body dementia with Dr. Kathleen Poston
19:28 - Alpha-synuclein and LBD diagnosis
26:45 - Advances in biomarkers
31:00 - Biomarker #1: SAA
38:28 - Biomarker #2: Peripheral Synuclein Detection
43:42 - Should I get this test done?
54:04 - Q&A session
While you're here, register for 'Unpacking Parkinsonism: Understanding Movement Changes in LBD,' on March 8 at 2:00pm ET for a presentation by Dr. Jori Fleisher, MD MSCE from LBDA’s Research Center of Excellence at Rush University Medical Center.
In this webinar you'll learn to define the various presentations of common movement symptoms in LBD, the medication and non-medication approaches to management, and how to identify the health care providers who should be in your team to help you address these changes.
Reserve your spot at ow.ly/cixG50QFWar

[@josephappio400]

What happens as my wife has become agitated , taking Razol 13:30